| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Hyperliquid Strategies Inc | Director | Common Stock | 41,671 | $156,266 | $3.75 | 09 Feb 2026 | Direct |
| Sonnet BioTherapeutics Holdings, Inc. | Director | Common Stock | 0 | $0 | $5.40 | 02 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PURR | Hyperliquid Strategies Inc | 09 Feb 2026 | 1 | $0 | 4 | Director | 11 Feb 2026, 19:35 |
| HYPS | Hyperliquid Strategies Inc | 02 Dec 2025 | 1 | $0 | 4 | Director | 23 Dec 2025, 13:03 |
| HYPS | Hyperliquid Strategies Inc | 02 Dec 2025 | 0 | $0 | 3 | Director | 23 Dec 2025, 12:59 |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | 02 Dec 2025 | 1 | $0 | 4 | Director | 03 Dec 2025, 21:12 |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | 11 Jul 2025 | 1 | $0 | 4 | Director | 15 Jul 2025, 19:35 |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | 11 Dec 2023 | 1 | $0 | 4 | Director | 05 Dec 2024, 21:55 |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | 30 May 2023 | 1 | +$10,883 | 4 | Director | 31 May 2023, 08:30 |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | 14 Dec 2022 | 1 | $0 | 4 | Director | 22 Dec 2022, 15:30 |
| SONN | Sonnet BioTherapeutics Holdings, Inc. | 15 Dec 2021 | 1 | $0 | 4 | Director | 08 Apr 2022, 16:30 |